FIELD: chemistry.
SUBSTANCE: invention relates to a sodium salt of diethyl ether of 4-oxo-1,4-dihydropyrazolo-[5,1-c]-1,2,4-triazine-3,8-dicarboxylic acid monohydrate, having antiglycating activity .
EFFECT: technical result is obtaining a novel compound, having antiglycating activity, which can be used for treating and preventing diabetes consequences.
1 cl, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF ANTIGLYCATING ACTIVITY IN SOLID DOSAGE FORM IN FORM OF CAPSULES AND METHOD FOR PREPARATION THEREOF | 2019 |
|
RU2738804C1 |
SODIUM SALT OF 3-NITRO-4-OXO-1,4-DIHYDROPYRAZOLO[5,1-c]-1,2,4-TRIAZINE-8-CARBOXYLIC ACID, DIHYDRATE | 2016 |
|
RU2641107C1 |
2-(5-NITRONYLFURAN-2-YL)-5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-A]PYRIMIDIN-7(4N)-ONE AND SALTS THEREOF | 2018 |
|
RU2716715C2 |
USE OF SODIUM SALT OF DIETHYL ESTER OF 4-OXO-1,4-DIHYDROPYRAZOLO[5,1-C]-1,2,4-TRIAZINE-3,8-DICARBOXYLIC ACID, MONOHYDRATE AS DRUG FOR TREATMENT AND PREVENTION OF LATE COMPLICATIONS OF DIABETES MELLITUS | 2019 |
|
RU2765117C2 |
USE OF HETEROCYCLIC HYDRAZONES AS AGENTS HAVING ANTIGLYCATING ACTIVITY | 2016 |
|
RU2658819C2 |
3-GUANIDINOAZOLO[1,2,4,5]TETRAZINES HAVING ANTIGLYCATING ACTIVITY AND A PROCESS FOR THEIR PREPARATION | 2017 |
|
RU2668971C1 |
APPLICATION OF SULFASALAZINE AS AN INHIBITOR OF THE FORMATION GLYCATION END PRODUCTS | 2017 |
|
RU2680844C1 |
BIS[1,2,4]TRIAZOLO[4,3-b:3',4'-f][1,2,4,5]TETRAZINES WITH ANTI-GLYCATING, ANTI-GLYCOXIDATION AND ANTIPLATELET ACTIVITY | 2020 |
|
RU2755897C1 |
INHIBITORS OF FORMATION OF GLYCATION END PRODUCTS BASED ON AZO-DERIVATIVE PHENYLSULPHONIC ACIDS | 2016 |
|
RU2634594C1 |
APPLICATION OF NITRO-DERIVATIVE PHENOL-SULPHONIC ACIDS AS INHIBITORS OF FINAL GLYCATION PRODUCTS FORMATION | 2016 |
|
RU2628605C1 |
Authors
Dates
2017-03-06—Published
2015-11-02—Filed